Edition:
India

Eidos Therapeutics Inc (EIDX.OQ)

EIDX.OQ on NASDAQ Stock Exchange Global Select Market

45.00USD
20 Aug 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$45.00
Open
$43.95
Day's High
$45.00
Day's Low
$43.72
Volume
81,118
Avg. Vol
54,105
52-wk High
$45.00
52-wk Low
$8.89

Latest Key Developments (Source: Significant Developments)

Bridgebio Pharma Submits Non-Binding Proposal To Acquire All Of Outstanding Shares Of Eidos Therapeutics That Are Not Owned By Bridgebio
Friday, 9 Aug 2019 

Aug 8 (Reuters) - Eidos Therapeutics Inc ::BRIDGEBIO PHARMA INC-SUBMITS NON-BINDING PROPOSAL TO ACQUIRE ALL OF OUTSTANDING SHARES OF STOCK OF EIDOS THERAPEUTICS THAT ARE NOT OWNED BY BRIDGEBI.BRIDGEBIO PHARMA INC- PROPOSAL FOR FIXED EXCHANGE RATIO OF 1.30 BRIDGEBIO SHARES FOR EACH SHARE OF EIDOS.BRIDGEBIO PHARMA, INC REPORTS 66.6% STAKE IN EIDOS THERAPEUTICS INC AS OF AUGUST 8, 2019 - SEC FILING.BRIDGEBIO - PROPOSAL VALUES EACH EIDOS SHARE AT $38.31.BRIDGEBIO - IN ITS CAPACITY AS A STOCKHOLDER OF EIDOS, HAS NO INTEREST IN SELLING CONTROL OF THE COMPANY.BRIDGEBIO - WILL NOT MOVE FORWARD WITH EIDOS PROPOSAL UNLESS APPROVED BY A SPECIAL COMMITTEE, AS ADVISED BY INDEPENDENT LEGAL & FINANCIAL ADVISORS.  Full Article

Eidos Therapeutics Reports Q1 Loss Per Share Of $0.32
Wednesday, 8 May 2019 

May 7 (Reuters) - Eidos Therapeutics Inc ::EIDOS THERAPEUTICS REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.32.Q1 EARNINGS PER SHARE ESTIMATE $-0.31 -- REFINITIV IBES DATA.CASH AND CASH EQUIVALENTS TOTALED $147.1 MILLION AT MARCH 31, 2019 COMPARED WITH $157.1 MILLION AT DECEMBER 31, 2018.  Full Article

Eidos Therapeutics Q3 Loss Per Share $0.29
Wednesday, 7 Nov 2018 

Nov 6 (Reuters) - Eidos Therapeutics Inc ::EIDOS THERAPEUTICS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q3 LOSS PER SHARE $0.29.Q3 EARNINGS PER SHARE VIEW $-0.27 -- THOMSON REUTERS I/B/E/S.  Full Article